A case report: Intermittent catheterization combined with rehabilitation in the treatment of carbapenem-resistant Klebsiella pneumoniae catheter-associated urinary tract infection

被引:2
|
作者
Shen, Lihua [1 ]
Wu, Heng [1 ,2 ,3 ]
Chen, Huiying [1 ]
Jiang, Yan [1 ,2 ,3 ]
机构
[1] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Infect Dis, Hangzhou, Peoples R China
[2] Key Lab Microbial Technol & Bioinformat Zhejiang P, Hangzhou, Peoples R China
[3] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Reg Med Ctr,Natl Inst Resp Dis, Hangzhou, Peoples R China
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2022年 / 12卷
关键词
intermittent catheterization; carbapenem-resistant Klebsiella pneumoniae; catheter-associated; urinary tract infection; rehabilitation; ENTEROBACTERIACEAE;
D O I
10.3389/fcimb.2022.1027576
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Catheter-related urinary tract infections, especially those caused by multidrug-resistant (MDR) bacteria, are extremely difficult to treat due to limited therapeutic choices. Therefore, removing catheters as soon as possible is pivotal to successful treatment. Herein, we report a case of catheter-related urinary tract infection caused by carbapenem-resistant Klebsiella pneumoniae (CRKP). Intermittent catheterization was used to reduce biofilm occurrence and exercise bladder function on the basis of an active and adequate anti-infection strategy. Simultaneously, combined with acupuncture treatment and strengthening the patient's pelvic floor muscle training to improve urinary retention, the catheter was eventually removed to obtain autonomous urination in this patient, and this led to the successful treatment for a CRKP catheter-related urinary tract infection.
引用
收藏
页数:5
相关论文
共 44 条
  • [41] Efficacy and Safety of Aerosol Inhalation of Colistin Sulfate for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infection in the Peri-Operative Period of Liver Transplantation: A Single-Center Retrospective Study
    Liu, Xiangyan
    Lu, Jianfang
    Wang, Zhuoyi
    Zhuang, Li
    Jiang, Guoping
    Shen, Tian
    Ma, Jincheng
    Zheng, Shusen
    SURGICAL INFECTIONS, 2024,
  • [42] First report of ISKpn26 element mediating mgrB gene disruption in the ST1 colistin- and carbapenem-resistant Klebsiella pneumoniae cluster isolated from a patient with chest infection
    Li, Xiaosi
    Shen, Siquan
    Feng, Yan
    Shen, Heping
    Hu, Fupin
    Wu, Xiaoyan
    MICROBIOLOGY SPECTRUM, 2024, 12 (11):
  • [43] Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model
    Hagihara, Mao
    Kato, Hideo
    Sugano, Toshie
    Okade, Hayato
    Sato, Nobuo
    Shibata, Yuichi
    Sakanashi, Daisuke
    Asai, Nobuhiro
    Koizumi, Yusuke
    Suematsu, Hiroyuki
    Yamagishi, Yuka
    Mikamo, Hiroshige
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (05)
  • [44] A Case of Successful Treatment of Recurrent Urinary Tract Infection by Extended-Spectrum β-Lactamase Producing Klebsiella pneumoniae Using Oral Lyophilized Fecal Microbiota Transplant
    Bier, Naomi
    Hanson, Blake
    Jiang, Zhi-Dong
    DuPont, Herbert L.
    Arias, Cesar A.
    Miller, William R.
    MICROBIAL DRUG RESISTANCE, 2023, 29 (01) : 34 - 38